JP2002527375A5 - - Google Patents

Download PDF

Info

Publication number
JP2002527375A5
JP2002527375A5 JP2000575480A JP2000575480A JP2002527375A5 JP 2002527375 A5 JP2002527375 A5 JP 2002527375A5 JP 2000575480 A JP2000575480 A JP 2000575480A JP 2000575480 A JP2000575480 A JP 2000575480A JP 2002527375 A5 JP2002527375 A5 JP 2002527375A5
Authority
JP
Japan
Prior art keywords
hydrochloride
starch
matrix
liquid
matrix material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000575480A
Other languages
English (en)
Japanese (ja)
Other versions
JP5408684B2 (ja
JP2002527375A (ja
Filing date
Publication date
Priority claimed from US09/233,443 external-priority patent/US7201923B1/en
Application filed filed Critical
Priority claimed from PCT/US1999/020905 external-priority patent/WO2000021504A1/en
Publication of JP2002527375A publication Critical patent/JP2002527375A/ja
Publication of JP2002527375A5 publication Critical patent/JP2002527375A5/ja
Application granted granted Critical
Publication of JP5408684B2 publication Critical patent/JP5408684B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000575480A 1998-10-09 1999-10-06 非連続な保存安定粒子を得るためにマトリックスに感受性液体成分を封入する方法 Expired - Lifetime JP5408684B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10370098P 1998-10-09 1998-10-09
US60/103,700 1998-10-09
US10969698P 1998-11-24 1998-11-24
US60/109,696 1998-11-24
US09/233,443 US7201923B1 (en) 1998-03-23 1999-01-20 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
US09/233,443 1999-01-20
PCT/US1999/020905 WO2000021504A1 (en) 1998-10-09 1999-10-06 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles

Publications (3)

Publication Number Publication Date
JP2002527375A JP2002527375A (ja) 2002-08-27
JP2002527375A5 true JP2002527375A5 (cg-RX-API-DMAC7.html) 2006-11-24
JP5408684B2 JP5408684B2 (ja) 2014-02-05

Family

ID=27379589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000575480A Expired - Lifetime JP5408684B2 (ja) 1998-10-09 1999-10-06 非連続な保存安定粒子を得るためにマトリックスに感受性液体成分を封入する方法

Country Status (13)

Country Link
EP (1) EP1119345B1 (cg-RX-API-DMAC7.html)
JP (1) JP5408684B2 (cg-RX-API-DMAC7.html)
AR (1) AR020729A1 (cg-RX-API-DMAC7.html)
AT (1) ATE429813T1 (cg-RX-API-DMAC7.html)
AU (1) AU777977B2 (cg-RX-API-DMAC7.html)
CA (1) CA2345815C (cg-RX-API-DMAC7.html)
CO (1) CO5150196A1 (cg-RX-API-DMAC7.html)
DE (1) DE69940821D1 (cg-RX-API-DMAC7.html)
DK (1) DK1119345T3 (cg-RX-API-DMAC7.html)
ES (1) ES2326502T3 (cg-RX-API-DMAC7.html)
PE (1) PE20001321A1 (cg-RX-API-DMAC7.html)
PT (1) PT1119345E (cg-RX-API-DMAC7.html)
WO (1) WO2000021504A1 (cg-RX-API-DMAC7.html)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
IL154142A0 (en) 2000-07-28 2003-07-31 Henkel Kgaa Novel amylolytic enzyme extracted from bacillus sp.a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2001291646A1 (en) * 2000-10-02 2002-04-15 Novozymes A/S Particles containing active in visco-elastic liquids
US6617026B2 (en) 2000-10-02 2003-09-09 Novozymes A/S Particles containing active in visco-elastic liquids
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US7431986B2 (en) 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
DE102004039196B4 (de) * 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
US7318920B2 (en) * 2004-09-27 2008-01-15 Ez-Med Company Low water activity nutritional product having beneficial microbial and high oil content
US20080281105A1 (en) * 2005-01-18 2008-11-13 Immusol Incorporated Novel Quinolinium Salts and Derivatives
EP1906911B1 (en) 2005-06-17 2019-09-25 Australian Nuclear Science And Technology Organisation Particles comprising a releasable dopant therein
AU2006257726B2 (en) * 2005-06-17 2010-09-09 Australian Nuclear Science And Technology Organisation Particles having hydrophobic material therein
KR20080021128A (ko) 2005-06-17 2008-03-06 오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 소수성 물질을 함유하는 입자
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
EP2366402A1 (en) 2005-12-16 2011-09-21 OxThera, Inc., Compositions and methods for oxalate reduction
PT3095447T (pt) 2006-02-03 2022-01-24 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
DK2037936T3 (da) 2006-06-21 2014-09-22 Opko Renal Llc Fremgangsmåde til behandling og forebyggelse af sekundær hyperparathyroidisme
US8703191B2 (en) 2006-07-25 2014-04-22 Intelgenx Corp. Controlled-release pharmaceutical tablets
ES3047207T3 (en) 2007-04-25 2025-12-03 Opko Renal Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
CA2683628C (en) 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
EP2148685A4 (en) 2007-04-25 2010-07-28 Cytochroma Inc METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
KR101691876B1 (ko) 2007-04-25 2017-01-02 사이토크로마 인코포레이티드 비타민 d 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
ES2593356T3 (es) 2008-04-02 2016-12-07 Opko Ireland Global Holdings, Ltd. Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
PL2318035T3 (pl) 2008-07-01 2019-10-31 Curemark Llc Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
JP5684725B2 (ja) 2009-01-06 2015-03-18 キュレロン リミテッド ライアビリティ カンパニー 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法
CA2747703C (en) 2009-01-06 2021-06-15 Curemark Llc Compositions and methods for the treatment or the prevention of infections by e. coli
DE202009001095U1 (de) 2009-01-26 2010-03-11 Igv Institut Für Getreideverarbeitung Gmbh Verkapselte Wirkstoffe in bioaktiver Matrix
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
CA2762824C (en) * 2009-06-05 2017-10-10 General Mills, Inc. Encapsulated omega-3 fatty acids for baked goods production
JP5810082B2 (ja) * 2009-07-03 2015-11-11 カーギル インコーポレイテッド 粒状フレーバー送達系、その製造方法及びその使用
US20110086085A1 (en) * 2009-10-13 2011-04-14 Wenzel Scott W Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US8926308B2 (en) 2010-04-21 2015-01-06 Intercontinental Great Brands Llc Dough extruders and methods
WO2012017012A1 (de) 2010-08-05 2012-02-09 Basf Se Stabilisator
DK2701733T3 (da) 2011-04-21 2019-05-27 Curemark Llc Forbindelser til behandling af neuropsykiatriske forstyrrelser
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US9560877B2 (en) 2012-03-13 2017-02-07 General Mills, Inc. Cereal-based product with improved eating quality fortified with dietary fiber and/or calcium
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
ES2856187T3 (es) 2013-05-31 2021-09-27 Victor Bronshtein Composiciones poliméricas que contienen productos biofarmacéuticos estables a temperatura ambiente y métodos para la formulación de las mismas
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2017108131A1 (en) * 2015-12-23 2017-06-29 Sonneveld Group B.V. Dough mixture comprising particles comprised of starch for the production of bakery products with an open crumb structure
JP5945087B1 (ja) * 2016-03-16 2016-07-05 株式会社大貴 排泄物処理材の製造方法及び製造装置
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법
JP7170540B2 (ja) * 2016-04-14 2022-11-14 マース インコーポレーテッド コク味を調節するためにカルシウム感知受容体活性を調節する化合物及びそれを含むペットフード製品
WO2018191233A1 (en) 2017-04-10 2018-10-18 Curemark, Llc Compositions for treating addiction
CN111867566A (zh) * 2018-03-15 2020-10-30 帝斯曼知识产权资产管理有限公司 包含维生素a的挤出物
WO2019175331A1 (en) * 2018-03-15 2019-09-19 Dsm Ip Assets B.V. Extrusion of oxidable actives
CN109432817A (zh) * 2018-11-02 2019-03-08 江阴天江药业有限公司 一种含热敏性有效成分的中药的自动化提取分离方法及配方颗粒制备方法
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
CN113350315B (zh) * 2021-06-10 2022-09-06 黑龙江澳利达奈德制药有限公司 一种别嘌醇缓释胶囊及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191015312A (en) 1910-06-25 1911-03-23 John Hutcheon Improved Process of Producing Cooked Foods Impregnated with certain Bacteria.
US3786123A (en) * 1971-01-25 1974-01-15 S Katzen Method for stabilizing and preserving nutrients and products
EP0202409A3 (en) 1985-03-25 1989-02-01 Miles Inc. A process for the production of viable and stable dry microorganisms for food and agricultural purposes
US5314692A (en) * 1987-08-24 1994-05-24 Cultor Ltd. Enzyme premix for feed and method
JP2695247B2 (ja) * 1988-06-13 1997-12-24 ビーエーエスエフ・ケー・アンド・エフ・コーポレイシヨン コレスチルアミンを含有する食用の焼いた組成物
WO1990015537A1 (en) 1989-06-07 1990-12-27 Nabisco Brands, Inc. Extrusion baking of cookies having liposome encapsulated ingredients
US5079012A (en) * 1989-06-07 1992-01-07 Nabisco Brands, Inc. Shelf stable cookie product containing heat and shear sensitive additives and method of making
JPH0463563A (ja) * 1990-07-03 1992-02-28 Terumo Corp 抗肥満性食品およびその製造方法
US5074902A (en) 1990-07-30 1991-12-24 Connick Jr William J Granular products containing fungi encapsulated in a wheat gluten matrix for biological control of weeds
DE4041752A1 (de) * 1990-12-24 1992-06-25 Henkel Kgaa Enzymzubereitung fuer wasch- und reinigungsmittel
US5508053A (en) 1993-08-13 1996-04-16 Kraft Foods, Inc. Method for producing vegetable pasta
ATE277739T1 (de) * 1996-10-28 2004-10-15 Gen Mills Inc Einbettung und einkapselung von teilchen zur kontrollierten abgabe
NZ501408A (en) * 1997-06-04 2002-02-01 Dsm N Carbohydrate-based enzyme granulates
WO1999048372A1 (en) 1998-03-23 1999-09-30 General Mills, Inc. Encapsulation of components into edible products

Similar Documents

Publication Publication Date Title
JP5408684B2 (ja) 非連続な保存安定粒子を得るためにマトリックスに感受性液体成分を封入する方法
US7201923B1 (en) Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
US8313757B2 (en) Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
CA2385696C (en) Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
EP0935523B1 (en) Embedding and encapsulation of controlled release particles
US8828432B2 (en) Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
EP1342548B1 (en) Embedding and encapsulation of controlled release particles and encapsulated product